A multi-omics study of bacterial growth arrest in a synthetic biology application
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA706951 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR13863600.fastq.gz | Fastqsanger.gz | |||
| SRR13863601.fastq.gz | Fastqsanger.gz | |||
| SRR13863602.fastq.gz | Fastqsanger.gz | |||
| SRR13863603.fastq.gz | Fastqsanger.gz | |||
| SRR13863604.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 18 |
Similar Datasets
Project description:Scaling up the functioning of synthetic circuits from microplates to bioreactors is far from trivial to achieve. We here test the scalability performance of a previously developed growth switch for increasing product yields in bacteria, based on external control of RNA polymerase expression. We show that, in liter-scale bioreactors operating in fed-batch mode, growth-arrested Escherichia coli cells are able to convert glucose to glycerol at an increased yield. A multi-omics quantification of the physiology of the cells shows that apart from acetate production, few metabolic side-effects occur, while a number of specific responses to growth slow-down and growth arrest are launched on the transcriptional level. These responses include the downregulation of genes involved in growth-associated processes, such as amino acid and nucleotide metabolism and translation, and the upregulation of a heat response. Interestingly, these transcriptional responses are buffered on the proteomic level, probably due to the strong decrease of the total mRNA concentration after the diminution of transcriptional activity and the absence of growth dilution of proteins. This transforms the growth-arrested cells into “bags of proteins“ with a functioning metabolism. More generally, the analysis shows that physiological characterization of bacterial cells hosting a synthetic circuit may reveal complex patterns of adaptation on different time-scales, dynamically interacting with the bioreactor environment.
2021-11-16 | GSE168336 | GEO
Project description:Scaling up the functioning of synthetic circuits from microplates to bioreactors is far from trivial to achieve. We here test the scalability performance of a previously developed growth switch for increasing product yields in bacteria, based on external control of RNA polymerase expression. We show that, in liter-scale bioreactors operating in fed-batch mode, growth-arrested Escherichia coli cells are able to convert glucose to glycerol at an increased yield. A multi-omics quantification of the physiology of the cells shows that apart from acetate production, few metabolic side-effects occur, while a number of specific responses to growth slow-down and growth arrest are launched on the transcriptional level. These responses include the downregulation of genes involved in growth-associated processes, such as amino acid and nucleotide metabolism and translation, and the upregulation of heat shock genes. Interestingly, these transcriptional responses are buffered on the proteomic level, probably due to the strong decrease of the total mRNA concentration after the diminution of transcriptional activity and the absence of growth dilution of proteins. This transforms the growth-arrested cells in “bags of proteins“ with a functioning metabolism. More generally, the analysis shows that physiological characterization of bacterial cells hosting a synthetic circuit may reveal complex patterns of adaptation on different time-scales, dynamically interacting with the bioreactor environment.
2021-11-25 | PXD024231 | Pride
Project description:These data files and results are supplementary material for the manuscript "PeakDecoder: A Machine Learning-Based Metabolite Identification Algorithm for Multidimensional Mass Spectrometry Measurements and its Application in Synthetic Biology".
2022-06-26 | MSV000089733 | MassIVE
Project description:Inferring in humans biological responses to external cues such as drugs, chemicals, viruses and hormones, is an essential question in biomedicine and cannot be easily studied in humans. Thus, biomedical research has continuously relied on animal models for studying the impact of these compounds and attempted to M-^StranslateM-^T the results to humans. In this context, the Systems Biology Verification for Industrial Methodology for Process Verification in Research (SBV IMPROVER) initiative had run a Species Translation Challenge for the scientific community to explore and understand the limit of translatability from rodent to human using systems biology. Therefore, a multi-layer omics dataset was generated that comprised of phosphoproteomics, transcriptomics and cytokine data derived from normal human (NHBE) and rat (NRBE) bronchial epithelial cells exposed in parallel to more than 50 different stimuli under identical conditions. The present manuscript describes in detail the experimental settings, the generation, processing and quality control analysis of the multi-layer omics dataset. The datasets are accessible in public repositories could be leveraged for further translation studies.
2014-06-10 | E-MTAB-2091 | biostudies-arrayexpress
Project description:Application of SPOT to Zn-treated HL-60 cells for multi-omics mechanism discovery. A time-resolved, multi-omics experiment using an aumtomated, unified sample preparation platform
2018-11-21 | PXD009149 | Pride
Project description:The role of archaeal histones in gene expression - a synthetic biology perspective
| PRJNA525015 | ENA
Project description:Plant synthetic biology holds promise for developing climate-resilient crop varieties particularly through advancements in engineering the chloroplast genome. However, the field faces limitations due to the scarcity of genetic tools and the long generation times of photosynthetic eukaryotes. To address these challenges, we established Chlamydomonas reinhardtii as a prototyping chassis for chloroplast synthetic biology, by significantly advancing plastome engineering tools. We developed an automation workflow that enabled the generation, handling, and analysis of 3,156 transplastomic Chlamydomonas strains and expanded the repertoire of selection markers for chloroplast transformation in Chlamydomonas to five, alongside establishing six new reporter genes. Moreover, we characterized over 140 regulatory parts, including promoters, UTRs, and intercistronic expression elements, all integrated within the Phytobrick cloning framework, for which we demonstrated a broad range of gene expression strength. Additionally, we explored library-based approaches to overcome the throughput limitations of biolistic chloroplast transformation. Finally, we demonstrated the utility of all tools by introducing a chloroplast-based synthetic photorespiration pathway. The high conservation of the chloroplast genetic system suggests that our findings in Chlamydomonas could be translated to advance chloroplast engineering in land plants and provides a prototyping platform for future crop improvements to address the challenges posed by a changing global climate.
2025-08-11 | PXD051642 | Pride
Project description:A chemical and synthetic biology approach to control plant membrane receptor kinase signaling
| PRJNA561509 | ENA
Project description:AbstractBladder cancer (BC) is the most common malignant tumor of the genitourinary system. The age of individuals diagnosed with BC tends to decrease in recent years. A variety of standard therapeutic options are available for the clinical management of BC, but limitations exist. It is difficult to surgically eliminate small lesions, while radiation and chemotherapy damage normal tissues, leading to severe side effects. Therefore, new approaches are required to improve the efficacy and specificity of BC treatment. Synthetic biology is a field emerging in the last decade that refers to biological elements, devices, and materials that are artificially synthesized according to users' needs. In this review, we discuss how to utilize genetic elements to regulate BC-related gene expression periodically and quantitatively to inhibit the initiation and progression of BC. In addition, the design and construction of gene circuits to distinguish cancer cells from normal cells to kill the former but spare the latter are elaborated. Then, we introduce the development of genetically modified T cells for targeted attacks on BC. Finally, synthetic nanomaterials specializing in detecting and killing BC cells are detailed. This review aims to describe the innovative details of the clinical diagnosis and treatment of BC from the perspective of synthetic biology.
| S-EPMC9771244 | biostudies-literature
Project description:Application of SPOT to Zn-treated HL-60 cells for multi-omics mechanism discovery. A time-resolved, multi-omics experiment using an automated, unified sample preparation platform. These datasets represent additional phosphoproteomics datasets(not prepared using SPOT) that were used along with the SPOT datasets for mechanism discovery
2018-11-21 | PXD009367 | Pride